1-149784140-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000566.4(FCGR1A):āc.190C>Gā(p.Gln64Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000566.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR1A | NM_000566.4 | c.190C>G | p.Gln64Glu | missense_variant | 3/6 | ENST00000369168.5 | NP_000557.1 | |
LOC124904411 | XM_047438183.1 | c.*577-880G>C | intron_variant | XP_047294139.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR1A | ENST00000369168.5 | c.190C>G | p.Gln64Glu | missense_variant | 3/6 | 1 | NM_000566.4 | ENSP00000358165 | P1 | |
FCGR1A | ENST00000444948.5 | c.31+1366C>G | intron_variant | 2 | ENSP00000394279 | |||||
H2BC18 | ENST00000545683.1 | c.378-880G>C | intron_variant | 2 | ENSP00000445831 | |||||
H2BC18 | ENST00000420462.1 | n.76-880G>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459700Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726154
GnomAD4 genome Cov.: 27
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.190C>G (p.Q64E) alteration is located in exon 3 (coding exon 3) of the FCGR1A gene. This alteration results from a C to G substitution at nucleotide position 190, causing the glutamine (Q) at amino acid position 64 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at